AUTO-GENERATED · CITATION-ONLY · 2026-07-27
$OTLK — convergence catalyst
Convergence score: 20 ·
Signals fired: 13
(darkpool;alpha;finra_short;gap;finra_regsho;xbrl_ni;sec_fda;pill;gamma;auto_macro_eia_petroleum;auto_macro_move_index;auto_macro_nbp_fx;auto_macro_options_gex) ·
Conviction: ELEVATED
Auto-generated from public filings. This is not financial advice.
Confirm independently before trading. Catalyst Edge holds positions consistent
with our published signals — see
trust report.
Citation block only. Automated narrative unavailable this cycle (reason: no_citations_in_summary).
Sources
- [1] SEC EDGAR · 8-K filing on 2026-07-24 · 2026-07-24T17:01:05
- [2] ALPHAVANTAGE · Outlook Therapeutics (NASDAQ:OTLK) suspended post-Lytenava approval, with funding under pressure from looming warrants · 2026-07-25T01:10:30
- [3] ALPHAVANTAGE · Outlook Therapeutics grants options to CEO Robert C. Jahr and CFO Lawrence A. Kenyon · 2026-07-24T09:40:28
- [4] ALPHAVANTAGE · Outlook Therapeutics (OTLK) Gets July 29 PDUFA Date for LYTENAVA · 2026-07-14T19:08:45
- [5] ALPHAVANTAGE · US FDA approves Outlook Therapeutics' eye disease drug · 2026-07-24T21:10:30
- [6] ALPHAVANTAGE · Outlook Therapeutics receives FDA approval for wet AMD treatment · 2026-07-24T19:10:30
- [7] Catalyst Edge convergence detector · Convergence score 20, 13 signals fired: darkpool, alpha, finra_short, gap, finra_regsho, xbrl_ni, sec_fda, pill, gamma, auto_macro_eia_petroleum, auto_macro_move_index, auto_macro_nbp_fx, auto_macro_options_gex · 2026-07-27T14:56:17
Underlying signal breakdown
| Field | Value |
|---|
| convergence_score | 20 |
| conviction_level | ELEVATED |
| signal_count | 13 |
| sector | biotech |
| price | |
⚠️ Position disclosure: Catalyst Edge holds
a small live equity position in tickers that pass the convergence + scoop
publish gate. Real-time P/L, fills, and the running ledger are public at
/trust/. Specific entry
on
OTLK: see
/scoreboard/
for outcome tracking. Bloomberg legally cannot disclose this; we do.
This filing was public at 4 AM. Most people priced it in at 9:47, after the move.
$99 once — the ranked list lands before the open, not after.
Tier 1 setups touched +2% intraday 48.9% of the time across 374 tracked calls. Baseline for everything else: 40.9%. That is a +8.0 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/
- Click Become a Founding Member below.
- Pay $99 once — not monthly, not ever again.
- You keep every future release at that price. Tomorrow's ranked list
lands at 3:30 AM ET, before the open.
29 of 30 founding seats left. The price goes up when they are gone.
Become a Founding Member — $99 once
One payment. Lifetime access. The free daily picks
stay free — this is for people who want the full console.
Not buying today? Get tomorrow's ranked list free →